Novartis AG (NOT)
XDUS
133.70
-0.66 (-0.49%)
Real-time Data
06:00 AM
Day's Range
133.70134.06
52 wk Range
102.70143.78
Financial Statements - NOT - Novartis AG
Revenue
56.67B▲ 29.3%
Net Income
13.96B▲ 38.1%Net Margin 24.6%
EBITDA
23.12B▲ 30.6%
Free Cash Flow
15.24B▲ 30.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 56.67B | 43.82B |
| Cost of Goods | 13.69B | 10.86B |
| Gross Profit | 42.97B | 32.96B |
 Operating Expense | - | - |
| Operating Income | 17.64B | 12.32B |
| Non-Operating Interest | - | - |
| Other Income Expense | -312M | -184.73M |
| Pre Tax Income | 16.35B | 11.55B |
| Income Tax | 2.38B | 1.44B |
| Net Income | 13.96B | 10.11B |
| EPS Basic | 7.21 | 5.92 |
| EPS Diluted | 7.15 | 5.87 |
| Basic Shares Outstanding | 1.93B | 1.71B |
| Diluted Shares Outstanding | 1.93B | 1.71B |
| Ebit | 17.49B | 12.41B |
| Ebitda | 23.12B | 17.70B |
| Net Income Continuous Operations | 13.96B | 10.11B |
| Minority Interests | 17M | 2M |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
